Based on our mechanism study of LAPTM4B, transcription factors and microRNA could bind to LAPTM4B promoter regions to regulate its expression and exert oncogenic effects in breast cancer [28–30]. This evidence concerns the gene LAPTM4B and breast carcinoma.